Trial Profile
A Randomized, Double-blind, Multi-center, Factorial Phase III Clinical Trial to Evaluate the Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary) ; Telmisartan (Primary)
- Indications Hyperlipidaemia; Hypertension
- Focus Therapeutic Use
- Sponsors Ildong Pharmaceutical
- 30 Nov 2015 New trial record